By Professor Mark Duncan Willcox

Journal articles

Phan MAT; Madigan MC; Stapleton F; Willcox M; Golebiowski B, 2022, 'Human meibomian gland epithelial cell culture models: Current progress, challenges, and future directions', Ocular Surface, 23, pp. 96 - 113, http://dx.doi.org/10.1016/j.jtos.2021.11.012

Kalaiselvan P; Tummanapalli SS; Kumar Vijay A; Bahl P; MacIntyre CR; Willcox MDP, 2022, 'The ability of face masks to reduce transmission of microbes', Clinical and Experimental Optometry, 105, pp. 214 - 221, http://dx.doi.org/10.1080/08164622.2021.1971050

Kalaiselvan P; Kuppusamy R; Kumar N; Willcox M, 2022, 'Antimicrobial activity of RK-7 peptide mimic against Staphylococcus aureus in solution and when immobilised onto contact lenses', Contact Lens and Anterior Eye, 45, pp. 101607 - 101607, http://dx.doi.org/10.1016/j.clae.2022.101607

Wulandari E; Budhisatria R; Soeriyadi AH; Willcox M; Boyer C; Wong EHH, 2021, 'Releasable antimicrobial polymer-silk coatings for combating multidrug-resistant bacteria', Polymer Chemistry, 12, pp. 7038 - 7047, http://dx.doi.org/10.1039/d1py01219c

Maulvi FA; Soni PD; Patel PJ; Desai AR; Desai DT; Shukla MR; Shah SA; Shah DO; Willcox MDP, 2021, 'Controlled bimatoprost release from graphene oxide laden contact lenses: In vitro and in vivo studies', Colloids and Surfaces B: Biointerfaces, 208, pp. 112096, http://dx.doi.org/10.1016/j.colsurfb.2021.112096

Maulvi FA; Desai DT; Shetty KH; Shah DO; Willcox MDP, 2021, 'Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery', International Journal of Pharmaceutics, 608, pp. 121090, http://dx.doi.org/10.1016/j.ijpharm.2021.121090

Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP, 2021, 'Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration', International Journal of Pharmaceutics, 608, pp. 121105, http://dx.doi.org/10.1016/j.ijpharm.2021.121105

Li Y; Ariotti N; Aghaei B; Pandzic E; Ganda S; Willcox M; Sanchez-Felix M; Stenzel M, 2021, 'Inhibition of S. aureus Infection of Human Umbilical Vein Endothelial Cells (HUVECs) by Trehalose- and Glucose-Functionalized Gold Nanoparticles', Angewandte Chemie - International Edition, 60, pp. 22652 - 22658, http://dx.doi.org/10.1002/anie.202106544

Li Y; Ariotti N; Aghaei B; Pandzic E; Ganda S; Willcox M; Sanchez‐Felix M; Stenzel M, 2021, 'Inhibition of S. aureus Infection of Human Umbilical Vein Endothelial Cells (HUVECs) by Trehalose‐ and Glucose‐Functionalized Gold Nanoparticles', Angewandte Chemie, 133, pp. 22834 - 22840, http://dx.doi.org/10.1002/ange.202106544

Chakraborty S; Kuppusamy R; Roohani I; Walsh WR; Willcox MDP; Kumar N; Chen R, 2021, 'Antibacterial peptidomimetic and characterization of its efficacy as an antibacterial and biocompatible coating for bioceramic-based bone substitutes', Materials Advances, 2, pp. 6369 - 6379, http://dx.doi.org/10.1039/d1ma00648g

Yasir M; Dutta D; Willcox MDP, 2021, 'Enhancement of antibiofilm activity of ciprofloxacin against staphylococcus aureus by administration of antimicrobial peptides', Antibiotics, 10, pp. 1159, http://dx.doi.org/10.3390/antibiotics10101159

Afzal M; Vijay AK; Stapleton F; Willcox MDP, 2021, 'Susceptibility of ocular staphylococcus aureus to antibiotics and multipurpose disinfecting solutions', Antibiotics, 10, pp. 1203, http://dx.doi.org/10.3390/antibiotics10101203

Yasir M; Dutta D; Willcox MDP, 2021, 'Enhancement of Antibiofilm Activity of Ciprofloxacin against Staphylococcus aureus by Administration of Antimicrobial Peptides', Antibiotics, 10, pp. 1 - 17, http://dx.doi.org/10.20944/preprints202108.0451.v1

Phan MAT; Madigan MC; Willcox M; Stapleton F; Golebiowski B, 2021, 'Semi-quantification of lipids in human meibomian gland epithelial cells using dual staining microplate assays', Experimental Eye Research, 210, pp. 108719, http://dx.doi.org/10.1016/j.exer.2021.108719

Datta A; Willcox MDP; Stapleton F, 2021, 'In vivo efficacy of silver-impregnated barrel contact lens storage cases', Contact Lens and Anterior Eye, 44, http://dx.doi.org/10.1016/j.clae.2020.08.001

Bhattacharjee S; Joshi R; Chughtai A; Heslop D; Wilcox M; MacIntyre R, 2021, 'Graphene and nanoparticles coated antimicrobial and biocompatible cotton/silk fabrics for protective clothing', ACS Applied Bio Materials

Yu TT; Kuppusamy R; Yasir M; Hassan MM; Sara M; Ho J; Willcox MDP; Black DS; Kumar N, 2021, 'Polyphenylglyoxamide‐based amphiphilic small molecular peptidomimetics as antibacterial agents with anti‐biofilm activity', International Journal of Molecular Sciences, 22, pp. 7344, http://dx.doi.org/10.3390/ijms22147344

Peguda HK; Mahbub SB; Sherpa TD; Subedi D; Habibalahi A; Anwer AG; Gu Z; Willcox MDP; Goldys EM; Carnt NA, 2021, 'The autofluorescence patterns of acanthamoeba castellanii, pseudomonas aeruginosa and staphylococcus aureus: Effects of antibiotics and tetracaine', Pathogens, 10, pp. 894, http://dx.doi.org/10.3390/pathogens10070894

Tummanapalli SS; Kuppusamy R; Yeo JH; Kumar N; New EJ; Willcox MDP, 2021, 'The role of nitric oxide in ocular surface physiology and pathophysiology', Ocular Surface, 21, pp. 37 - 51, http://dx.doi.org/10.1016/j.jtos.2021.04.007

Efron N; Brennan NA; Chalmers RL; Jones L; Lau C; Morgan PB; Nichols JJ; Szczotka-Flynn LB; Willcox MD, 2021, 'Authors’ Reply: “Thirty years of ‘quiet eye’ with etafilcon A contact lenses: Additional considerations”', Contact Lens and Anterior Eye, 44, http://dx.doi.org/10.1016/j.clae.2020.06.003

Ozkan J; Majzoub ME; Coroneo M; Thomas T; Willcox M, 2021, 'Comparative analysis of ocular surface tissue microbiome in human, mouse, rabbit, and guinea pig', Experimental Eye Research, 207, pp. 108609, http://dx.doi.org/10.1016/j.exer.2021.108609

Nakagawa M; Nakagawa R; Willcox MDP; Vijay AK, 2021, 'Effect of Hygiene Procedures on Lens Case Contamination with Povidone-Iodine or Multipurpose Disinfecting Solutions', Optometry and Vision Science, 98, pp. 563 - 569, http://dx.doi.org/10.1097/OPX.0000000000001700

Masoudi S; Mitchell TW; Willcox MD, 2021, 'Profiling of non-polar lipids in tears of contact lens wearers during the day', Experimental Eye Research, 207, http://dx.doi.org/10.1016/j.exer.2021.108567

Konda N; Kaur I; Garg P; Chakrabarti S; Willcox MDP, 2021, 'Toll-like receptor gene polymorphisms in patients with keratitis', Contact Lens and Anterior Eye, 44, http://dx.doi.org/10.1016/j.clae.2020.07.003

Rayamajhee B; Willcox M; Henriquez FL; Petsoglou C; Carnt N, 2021, 'Acanthamoeba keratitis - an increasingly common infectious disease of the cornea', The Lancet Microbe, 2, pp. e345 - e346, http://dx.doi.org/10.1016/S2666-5247(21)00093-8

Jones L; Hui A; Phan CM; Read ML; Azar D; Buch J; Ciolino JB; Naroo SA; Pall B; Romond K; Sankaridurg P; Schnider CM; Terry L; Willcox M, 2021, 'CLEAR - Contact lens technologies of the future', Contact Lens and Anterior Eye, 44, pp. 398 - 430, http://dx.doi.org/10.1016/j.clae.2021.02.007

Willcox M; Keir N; Maseedupally V; Masoudi S; McDermott A; Mobeen R; Purslow C; Santodomingo-Rubido J; Tavazzi S; Zeri F; Jones L, 2021, 'CLEAR - Contact lens wettability, cleaning, disinfection and interactions with tears', Contact Lens and Anterior Eye, 44, pp. 157 - 191, http://dx.doi.org/10.1016/j.clae.2021.02.004

Morgan PB; Murphy PJ; Gifford KL; Gifford P; Golebiowski B; Johnson L; Makrynioti D; Moezzi AM; Moody K; Navascues-Cornago M; Schweizer H; Swiderska K; Young G; Willcox M, 2021, 'CLEAR - Effect of contact lens materials and designs on the anatomy and physiology of the eye', Contact Lens and Anterior Eye, 44, pp. 192 - 219, http://dx.doi.org/10.1016/j.clae.2021.02.006

Wolffsohn JS; Morgan PB; Barnett M; Downie LE; Jacobs DS; Jones L; Richdale K; Stapleton F; Vincent SJ; Willcox M, 2021, 'Contact Lens Evidence-Based Academic Reports (CLEAR)', Contact Lens and Anterior Eye, 44, pp. 129 - 131, http://dx.doi.org/10.1016/j.clae.2021.02.011

Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS, 2021, 'Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial', Ocular Surface, 20, pp. 62 - 69, http://dx.doi.org/10.1016/j.jtos.2020.12.006

Khan M; Willcox MDP; Rice SA; Sharma S; Stapleton F, 2021, 'Development of antibiotic resistance in the ocular Pseudomonas aeruginosa clone ST308 over twenty years', Experimental Eye Research, 205, http://dx.doi.org/10.1016/j.exer.2021.108504

Szczotka-Flynn LB; Shovlin JP; Schnider CM; Caffery BE; Alfonso EC; Carnt NA; Chalmers RL; Collier S; Jacobs DS; Joslin CE; Kroken AR; Lakkis C; Pearlman E; Schein OD; Stapleton F; Tu E; Willcox MDP, 2021, 'American Academy of Optometry Microbial Keratitis Think Tank', Optometry and Vision Science, 98, pp. 182 - 198, http://dx.doi.org/10.1097/OPX.0000000000001664

Sabir S; Yu TT; Kuppusamy R; Almohaywi B; Iskander G; Das T; Willcox MDP; Black DS; Kumar N, 2021, 'Novel seleno-and thio-urea-containing dihydropyrrol-2-one analogues as antibacterial agents', Antibiotics, 10, pp. 321, http://dx.doi.org/10.3390/antibiotics10030321

Rayamajhee B; Subedi D; Peguda HK; Willcox MD; Henriquez FL; Carnt N, 2021, 'A systematic review of intracellular microorganisms within acanthamoeba to understand potential impact for infection', Pathogens, 10, pp. 1 - 25, http://dx.doi.org/10.3390/pathogens10020225

Konda N; Garg P; Sharma S; Willcox MDP, 2021, 'Risk Factors for Contact Lens-Related Microbial Keratitis and Associated Vision Loss in a South Indian Population', Eye and Contact Lens, 47, pp. 118 - 126, http://dx.doi.org/10.1097/ICL.0000000000000737

Echeverria CA; Ozkan J; Pahlevani F; Willcox M; Sahajwalla V, 2021, 'Effect of hydrothermal hot-compression method on the antimicrobial performance of green building materials from heterogeneous cellulose wastes', Journal of Cleaner Production, 280, pp. 124377, http://dx.doi.org/10.1016/j.jclepro.2020.124377

Masoudi S; Willcox M, 2021, 'A method for studying lipid adsorption to silicone hydrogel contact lenses', Biofouling, 37, pp. 862 - 878, http://dx.doi.org/10.1080/08927014.2021.1978433

Tummanapalli SS; Willcox MD, 2021, 'Antimicrobial resistance of ocular microbes and the role of antimicrobial peptides', Clinical and Experimental Optometry, 104, pp. 295 - 307, http://dx.doi.org/10.1111/cxo.13125

Ozkan J; Coroneo M; Sandbach J; Subedi D; Willcox M; Thomas T, 2021, 'Bacterial contamination of intravitreal needles by the ocular surface microbiome', Ocular Surface, 19, pp. 169 - 175, http://dx.doi.org/10.1016/j.jtos.2020.05.010

Kalaiselvan P; Konda N; Pampi N; Vaddavalli PK; Sharma S; Stapleton F; Kumar N; Willcox MDP; Dutta D, 2021, 'Effect of antimicrobial contact lenses on corneal infiltrative events: A randomized clinical trial', Translational Vision Science and Technology, 10, pp. 32 - 32, http://dx.doi.org/10.1167/tvst.10.7.32

Cho K; Yasir M; Jung M; Willcox MDP; Stenzel MH; Rajan G; Farrar P; Prusty BG, 2020, 'Hybrid engineered dental composites by multiscale reinforcements with chitosan-integrated halloysite nanotubes and S-glass fibers', Composites Part B: Engineering, 202, http://dx.doi.org/10.1016/j.compositesb.2020.108448

Rayamajhee B; Subedi D; Won S; Kim J; Vijay A; Tan J; Henriquez FL; Willcox M; Carnt NA; Showyin J, 2020, 'Investigating domestic shower settings as a risk factor for acanthamoeba keratitis', Water (Switzerland), 12, pp. 1 - 12, http://dx.doi.org/10.3390/w12123493

Khan M; Summers S; Rice SA; Stapleton F; Willcox MDP; Subedi D, 2020, 'Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa', Infection, Genetics and Evolution, 85, pp. 104574, http://dx.doi.org/10.1016/j.meegid.2020.104574

Lace R; Doherty KG; Dutta D; Willcox MDP; Williams RL, 2020, 'Poly-ε-Lysine or Mel4 Antimicrobial Surface Modification on a Novel Peptide Hydrogel Bandage Contact Lens', Advanced Materials Interfaces, 7, http://dx.doi.org/10.1002/admi.202001232

Browne K; Chakraborty S; Chen R; Willcox MDP; Black DS; Walsh WR; Kumar N, 2020, 'A new era of antibiotics: The clinical potential of antimicrobial peptides', International Journal of Molecular Sciences, 21, pp. 1 - 23, http://dx.doi.org/10.3390/ijms21197047

Shahzad S; Willcox M, 2020, 'Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll', Medical Hypotheses, 143, pp. 110080, http://dx.doi.org/10.1016/j.mehy.2020.110080

Erickson S; Sullivan AG; Barabino S; Begovic E; Benitez-del-Castillo JM; Bonini S; Borges JS; Brzheskiy V; Bulat N; Cerim A; Craig JP; Cușnir V; Cușnir V; Doan S; Dülger E; Farrant S; Geerling G; Goldblum D; Golubev S; Gomes JAP; González-Méijome JM; Grupcheva CN; Gündüz Ö; Horwath-Winter J; Källmark F; Karanadze N; Karcic HH; Karcic S; Kontadakis G; Messmer EM; Mrugacz M; Murphy C; O'Leary OE; Procopciuc V; Pult H; Raus P; Şahin A; Setälä N; Stanila A; Stanila DM; Utheim TP; Vehof J; Versura P; Villani E; Willcox MDP; Wolffsohn JS; Zagórski Z; Zoega GM; Sullivan DA, 2020, 'TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases', Ocular Surface, 18, pp. 936 - 962, http://dx.doi.org/10.1016/j.jtos.2020.05.006

Yu TT; Kuppusamy R; Yasir M; Hassan MM; Alghalayini A; Gadde S; Deplazes E; Cranfield C; Willcox MDP; Black DS; Kumar N, 2020, 'Design, synthesis and biological evaluation of biphenylglyoxamide-based small molecular antimicrobial peptide mimics as antibacterial agents', International Journal of Molecular Sciences, 21, pp. 1 - 38, http://dx.doi.org/10.3390/ijms21186789

Yasir M; Dutta D; Willcox MDP, 2020, 'Activity of Antimicrobial Peptides and Ciprofloxacin against Pseudomonas aeruginosa Biofilms', Molecules, 25, pp. 3843, http://dx.doi.org/10.3390/molecules25173843

Khan M; Stapleton F; Summers S; Rice SA; Willcox MDP, 2020, 'Antibiotic resistance characteristics of pseudomonas aeruginosa isolated from keratitis in Australia and India', Antibiotics, 9, pp. 1 - 16, http://dx.doi.org/10.3390/antibiotics9090600

Back to profile page